Click on headlines below to download research

Self-commercialization gains favor
SymBio Pharmaceuticals | 09/04/2018

With the lifecycle of Treakisym extended through the in-licensing of liquid formulations from Eagle in 2017, SymBio is refining its plans to establish…

Self-commercialisation gains favour
SymBio Pharmaceuticals | 06/04/2018

With the lifecycle of Treakisym extended through the in-licensing of liquid formulations from Eagle in 2017, SymBio is refining its plans to establish…

Licence agreement for IONSYS terminated
SymBio Pharmaceuticals | 15/12/2017

The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in Japan has…